The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

Recurrent and multiple bladder tumors show conserved expression profiles.


  • David Lindgren
  • Sigurdur Gudjonsson
  • Kowan Ja Jee
  • Fredrik Liedberg
  • Sonja Aits
  • Anna Andersson
  • Gunilla Chebil
  • Åke Borg
  • Sakari Knuutila
  • Thoas Fioretos
  • Wiking Månsson
  • Mattias Höglund

Summary, in English

BACKGROUND: Urothelial carcinomas originate from the epithelial cells of the inner lining of the bladder and may appear as single or as multiple synchronous tumors. Patients with urothelial carcinomas frequently show recurrences after treatment making follow-up necessary. The leading hypothesis explaining the origin of meta- and synchronous tumors assumes a monoclonal origin. However, the genetic relationship among consecutive tumors has been shown to be complex in as much as the genetic evolution does not adhere to the chronological appearance of the metachronous tumors. Consequently, genetically less evolved tumors may appear chronologically later than genetically related but more evolved tumors. METHODS: Forty-nine meta- or synchronous urothelial tumors from 22 patients were analyzed using expression profiling, conventional CGH, LOH, and mutation analyses. RESULTS: We show by CGH that partial chromosomal losses in the initial tumors may not be present in the recurring tumors, by LOH that different haplotypes may be lost and that detected regions of LOH may be smaller in recurring tumors, and that mutations present in the initial tumor may not be present in the recurring ones. In contrast we show that despite apparent genomic differences, the recurrent and multiple bladder tumors from the same patients display remarkably similar expression profiles. CONCLUSION: Our findings show that even though the vast majority of the analyzed meta- and synchronous tumors from the same patients are not likely to have originated directly from the preceding tumor they still show remarkably similar expressions profiles. The presented data suggests that an expression profile is established early in tumor development and that this profile is stable and maintained in recurring tumors.


  • Division of Clinical Genetics
  • Breastcancer-genetics
  • Urology
  • Division of Microbiology, Immunology and Glycobiology - MIG

Publishing year





BMC Cancer




June 30

Document type

Journal article


BioMed Central (BMC)


  • Cancer and Oncology



Research group

  • Urology


  • ISSN: 1471-2407